These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 17097982

  • 1. Incidence of de novo nonmelanoma skin tumors after liver transplantation for alcoholic and nonalcoholic liver diseases.
    Jiménez-Romero C, Manrique Municio A, Marqués Medina E, Colina F, Ortega Domene P, Gómez Sanz R, Meneu Diaz JC, Abradelo de Usera M, Moreno Elola A, Moreno Gonzalez E.
    Transplant Proc; 2006 Oct; 38(8):2505-7. PubMed ID: 17097982
    [Abstract] [Full Text] [Related]

  • 2. Incidence and risk factors of development of lung tumors after liver transplantation.
    Jiménez C, Marqués E, Manrique A, Loinaz C, Gómez R, Meneu JC, Abradelo M, Pérez B, Moreno A, García I, Moreno E.
    Transplant Proc; 2005 Nov; 37(9):3970-2. PubMed ID: 16386600
    [Abstract] [Full Text] [Related]

  • 3. Incidence and risk factors for the development of lung tumors after liver transplantation.
    Jiménez C, Manrique A, Marqués E, Ortega P, Loinaz C, Gómez R, Meneu JC, Abradelo M, Moreno A, López A, Moreno E.
    Transpl Int; 2007 Jan; 20(1):57-63. PubMed ID: 17181654
    [Abstract] [Full Text] [Related]

  • 4. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
    Saigal S, Norris S, Muiesan P, Rela M, Heaton N, O'Grady J.
    Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349
    [Abstract] [Full Text] [Related]

  • 5. Development of lymphoproliferative disease after liver transplantation.
    Marqués E, Jiménez C, Manrique A, Vallejo GH, Clemares M, Ortega P, Moreno E.
    Transplant Proc; 2008 Nov; 40(9):2988-9. PubMed ID: 19010169
    [Abstract] [Full Text] [Related]

  • 6. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
    Baccarani U, Adani GL, Montanaro D, Risaliti A, Lorenzin D, Avellini C, Tulissi P, Groppuzzo M, Currò G, Luvisetto F, Beltrami A, Bresadola V, Viale PL, Bresadola F.
    Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
    [Abstract] [Full Text] [Related]

  • 7. Rapid development of esophageal squamous cell carcinoma after liver transplantation for alcohol-induced cirrhosis.
    Kenngott S, Gerbes AL, Schauer R, Bilzer M.
    Transpl Int; 2003 Sep; 16(9):639-41. PubMed ID: 12768231
    [Abstract] [Full Text] [Related]

  • 8. Cancers of new appearance in liver transplant recipients: incidence and evolution.
    Romero-Vargas ME, Flores-Cortés M, Valera Z, Gómez-Bravo MA, Barrera-Pulido L, Pareja-Ciuró F, Serrano Díez-Canedo J, García I, Bernardos A.
    Transplant Proc; 2006 Oct; 38(8):2508-10. PubMed ID: 17097983
    [Abstract] [Full Text] [Related]

  • 9. [Incidence of de novo neoplasms after liver transplantation].
    Berenguer M, Prieto M, Bustamante M, Carrasco D, López-Andújar R, Mir J, Berenguer J.
    Med Clin (Barc); 1998 Oct 24; 111(13):481-4. PubMed ID: 9859063
    [Abstract] [Full Text] [Related]

  • 10. Indications and management of everolimus after liver transplantation.
    Bilbao I, Sapisochin G, Dopazo C, Lazaro JL, Pou L, Castells L, Caralt M, Blanco L, Gantxegi A, Margarit C, Charco R.
    Transplant Proc; 2009 Oct 24; 41(6):2172-6. PubMed ID: 19715864
    [Abstract] [Full Text] [Related]

  • 11. Alcohol recidivism impairs long-term patient survival after orthotopic liver transplantation for alcoholic liver disease.
    Cuadrado A, Fábrega E, Casafont F, Pons-Romero F.
    Liver Transpl; 2005 Apr 24; 11(4):420-6. PubMed ID: 15776421
    [Abstract] [Full Text] [Related]

  • 12. De novo esophageal neoplasia after liver transplantation.
    Presser SJ, Schumacher G, Neuhaus R, Thuss-Patience P, Stieler J, Neuhaus P.
    Liver Transpl; 2007 Mar 24; 13(3):443-50. PubMed ID: 17318861
    [Abstract] [Full Text] [Related]

  • 13. Low recurrence of preexisting extrahepatic malignancies after liver transplantation.
    Benten D, Sterneck M, Panse J, Rogiers X, Lohse AW.
    Liver Transpl; 2008 Jun 24; 14(6):789-98. PubMed ID: 18412260
    [Abstract] [Full Text] [Related]

  • 14. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
    Ferraz-Neto BH, Hidalgo R, Thomé T, Melo VA, Lobue A, Zurstrassen MP, Moraes JM, Meira-Filho SP, Rezende MB, Fonseca LE, Pandullo FL, Soeiro FS, Afonso RC.
    Transplant Proc; 2007 Oct 24; 39(8):2511-3. PubMed ID: 17954160
    [Abstract] [Full Text] [Related]

  • 15. Inflammatory bowel disease after liver transplantation: a role for cytomegalovirus infection.
    Verdonk RC, Haagsma EB, Van Den Berg AP, Karrenbeld A, Slooff MJ, Kleibeuker JH, Dijkstra G.
    Scand J Gastroenterol; 2006 Feb 24; 41(2):205-11. PubMed ID: 16484126
    [Abstract] [Full Text] [Related]

  • 16. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
    Aguilera V, Berenguer M, Rubín A, San-Juan F, Rayón JM, Prieto M, Mir J.
    Liver Transpl; 2009 Jan 24; 15(1):79-87. PubMed ID: 19109849
    [Abstract] [Full Text] [Related]

  • 17. De novo nonalcoholic fatty liver disease after liver transplantation.
    Seo S, Maganti K, Khehra M, Ramsamooj R, Tsodikov A, Bowlus C, McVicar J, Zern M, Torok N.
    Liver Transpl; 2007 Jun 24; 13(6):844-7. PubMed ID: 17029282
    [Abstract] [Full Text] [Related]

  • 18. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease.
    Pfitzmann R, Schwenzer J, Rayes N, Seehofer D, Neuhaus R, Nüssler NC.
    Liver Transpl; 2007 Feb 24; 13(2):197-205. PubMed ID: 17205563
    [Abstract] [Full Text] [Related]

  • 19. Effects of everolimus monotherapy on hematological parameters and iron homeostasis in de novo liver transplant recipients: preliminary results.
    Masetti M, Rompianesi G, Montalti R, Romano A, Spaggiari M, Ballarin R, Guerrini GP, Gerunda GE.
    Transplant Proc; 2008 Feb 24; 40(6):1947-9. PubMed ID: 18675097
    [Abstract] [Full Text] [Related]

  • 20. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors.
    Kelly DM, Emre S, Guy SR, Miller CM, Schwartz ME, Sheiner PA.
    Cancer; 1998 Sep 15; 83(6):1237-43. PubMed ID: 9740091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.